secukinumab
novartis
['secukinumab']
kiltz et al. greater efficacy of secukinumab in normal bmi than high bmi as patients. decremental effect with increasing bmi. #acr22 abstr#1495 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC